UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$235M |
| 2 |
Microsoft
MSFT
|
+$176M |
| 3 |
Cognizant
CTSH
|
+$150M |
| 4 |
Chubb
CB
|
+$107M |
| 5 |
Under Armour
UAA
|
+$100M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$221M |
| 2 |
Workday
WDAY
|
+$133M |
| 3 |
Pfizer
PFE
|
+$122M |
| 4 |
Apple
AAPL
|
+$122M |
| 5 |
Nike
NKE
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 14.7% |
| 3 | Financials | 13.4% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Reinsurance Group of America
RGA
$15.6B
| $6.79M | 0.01% |
70,536
-10,518
| -13% | -$926K |
|
902
Sumitomo Mitsui Financial
SMFG
$163B
| $6.73M | 0.01% |
1,119,487
+777,761
| +228% | +$4.85M |
|
|
PTLA
903
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $6.72M | 0.01% |
329,314
+129,793
| +65% | +$4.12M |
|
|
CPE
904
DELISTED
Callon Petroleum Company
CPE
| $6.71M | 0.01% |
75,765
-4,068
| -5% | -$283K |
|
|
BLUE
905
DELISTED
bluebird bio
BLUE
| $6.7M | 0.01% |
12,172
+92
| +0.8% | +$56.5K |
|
|
MBLY
906
DELISTED
Mobileye N.V.
MBLY
| $6.68M | 0.01% |
179,256
-1,032,577
| -85% | -$32.9M |
|
907
AMC Global Media
AMCX
$493M
| $6.58M | 0.01% |
101,284
+6,471
| +7% | +$443K |
|
908
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $6.57M | 0.01% |
227,900
-51,670
| -18% | -$1.38M |
|
909
HEICO Corp Class A
HEI.A
$36.7B
| $6.57M | 0.01% |
336,812
+306,539
| +1,013% | +$5.62M |
|
910
Vail Resorts
MTN
$5.26B
| $6.55M | 0.01% |
49,017
+6,415
| +15% | +$803K |
|
|
EQC
911
DELISTED
Equity Commonwealth
EQC
| $6.54M | 0.01% |
231,852
-72,998
| -24% | -$1.97M |
|
|
BUFF
912
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $6.53M | 0.01% |
254,430
-8,896
| -3% | -$171K |
|
|
NFX
913
DELISTED
Newfield Exploration
NFX
| $6.46M | 0.01% |
194,281
+7,358
| +4% | +$208K |
|
|
RPAI
914
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $6.45M | 0.01% |
406,852
-122,275
| -23% | -$1.84M |
|
|
VAL
915
DELISTED
Valspar
VAL
| $6.43M | 0.01% |
60,128
-7,312
| -11% | -$603K |
|
916
Telefônica Brasil
VIV
$19.4B
| $6.41M | 0.01% |
513,300
-150,900
| -23% | -$1.47M |
|
|
FEIC
917
DELISTED
FEI COMPANY
FEIC
| $6.39M | 0.01% |
71,845
+41,600
| +138% | +$3.22M |
|
918
Healthcare Realty
HR
$6.94B
| $6.38M | 0.01% |
216,866
-68,171
| -24% | -$1.89M |
|
919
iShares TIPS Bond ETF
TIP
$14.5B
| – | – |
0
| – | – |
|
920
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
| – | – |
0
| – | – |
|
921
Avis
CAR
$4.96B
| $6.33M | 0.01% |
231,339
+7,014
| +3% | +$192K |
|
|
KTWO
922
DELISTED
K2M Group Holdings, Inc
KTWO
| $6.31M | 0.01% |
425,606
+1,596
| +0.4% | +$21.9K |
|
|
S
923
DELISTED
Sprint Corporation
S
| $6.31M | 0.01% |
1,812,952
-53,528
| -3% | -$171K |
|
|
ROIC
924
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $6.28M | 0.01% |
312,217
-65,840
| -17% | -$1.22M |
|
925
Visteon
VC
$2.76B
| $6.21M | 0.01% |
77,976
+1,007
| +1% | +$79.3K |
|
Similar funds
UBS AM's Q1 2016 Portfolio in Review
As of Q1 2016, UBS AM held 2,740 positions worth $86.2B, down 1.7% from $87.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q1 2016 filing shows 51 new, 583 increased, 1,774 reduced and 113 closed positions. Its largest new stake was NXP Semiconductors: 1,291,575 shares worth $105M. The largest sale was Thermo Fisher Scientific, an estimated $221M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q1 2016 buy was NXP Semiconductors: 1,291,575 shares worth $105M.
- UBS AM added most to Alibaba in Q1 2016, an estimated $235M increase.
- UBS AM's biggest Q1 2016 reduction was Thermo Fisher Scientific, cutting an estimated $221M.
- UBS AM fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $97.5M.
- UBS AM's ten largest holdings make up 15% of its $86.2B portfolio in Q1 2016.
- UBS AM opened 51 new positions and closed 113 in Q1 2016.
- UBS AM's portfolio value fell 1.7% quarter-over-quarter to $86.2B.
Based on UBS AM's 13F filing for Q1 2016, filed 12 May 2016.